-
1
المؤلفون: Wilkinson, Tom, Dixon, Rupert, Page, Clive, Carroll, Miles, Griffiths, Gareth, Ho, Ling-Pei, De Soyza, Anthony, Felton, Timothy, Lewis, Keir E, Phekoo, Karen, Chalmers, James D, Gordon, Anthony, McGarvey, Lorcan, Doherty, Jillian, Read, Robert C, Shankar-Hari, Manu, Martinez-Alier, Nuria, O'Kelly, Michael, Duncan, Graeme, Walles, Roelize, Sykes, James, Summers, Charlotte, Singh, Dave, ACCORD Collaborators
المساهمون: NIHR, National Institute for Health Research, Summers, Charlotte [0000-0002-7269-2873], Apollo - University of Cambridge Repository
المصدر: Trials, Vol 21, Iss 1, Pp 1-3 (2020)
Wilkinson, T, Dixon, R, Page, C, Carroll, M, Griffiths, G, Ho, L, De Soyza, A, Felton, T, Lewis, K E, Phekoo, K, Chalmers, J D, Gordon, A, Mcgarvey, L, Doherty, J, Read, R C, Shankar-hari, M, Martinez-alier, N, O’kelly, M, Duncan, G, Walles, R, Sykes, J, Summers, C & Singh, D 2020, ' ACCORD: A Multicentre, Seamless, Phase 2 Adaptive Randomisation Platform Study to Assess the Efficacy and Safety of Multiple Candidate Agents for the Treatment of COVID-19 in Hospitalised Patients: A structured summary of a study protocol for a randomised controlled trial ', Trials, vol. 21, no. 1 . https://doi.org/10.1186/s13063-020-04584-9
ACCORD Collaborators 2020, ' ACCORD: A Multicentre, Seamless, Phase 2 Adaptive Randomisation Platform Study to Assess the Efficacy and Safety of Multiple Candidate Agents for the Treatment of COVID-19 in Hospitalised Patients: A structured summary of a study protocol for a randomised controlled trial ', Trials, vol. 21, no. 1, 691 . https://doi.org/10.1186/s13063-020-04584-9
Trialsمصطلحات موضوعية: Letter, Benzamides/therapeutic use, medicine.medical_treatment, Medicine (miscellaneous), Spike Glycoprotein, Coronavirus/antagonists & inhibitors, law.invention, platform study, 0302 clinical medicine, Randomized controlled trial, law, Oxygen therapy, Pharmacology (medical), 030212 general & internal medicine, Stage (cooking), 1102 Cardiorespiratory Medicine and Haematology, Randomized Controlled Trials as Topic, Response rate (survey), lcsh:R5-920, master protocol, Standard of Care, phase II, Antiviral Agents/adverse effects, Hospitalization, Pyrazines, Benzamides, Spike Glycoprotein, Coronavirus, lcsh:Medicine (General), randomised, Coronavirus Infections, medicine.medical_specialty, Blinding, Randomization, Pneumonia, Viral, Antiviral Agents, 03 medical and health sciences, Betacoronavirus, General & Internal Medicine, Internal medicine, medicine, Humans, Pandemics, Protocol (science), business.industry, SARS-CoV-2, COVID-19, 1103 Clinical Sciences, Coronavirus Infections/drug therapy, Pneumonia, Viral/drug therapy, COVID-19 Drug Treatment, Pyrazines/therapeutic use, Cardiovascular System & Hematology, Sample size determination, business, 030217 neurology & neurosurgery
وصف الملف: text; application/pdf
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::138961db3336962d1efc56acb1dcabd7
-
2
المؤلفون: Chalandon, Yves, Thomas, Xavier, Hayette, Sandrine, Cayuela, Jean-Michel, Abbal, Claire, Huguet, Françoise, Raffoux, Emmanuel, Leguay, Thibaut, Rousselot, Philippe, Lepretre, Stéphane, Escoffre-Barbe, Martine, Maury, Sébastien, Berthon, Céline, Tavernier, Emmanuelle, Lambert, Jean-François, Lafage-Pochitaloff, Marina, Lhéritier, Véronique, Chevret, Sylvie, Ifrah, Norbert, Dombret, Hervé, Group for Research on Adult Acute Lymphoblastic Leukemia (GRAALL)
المصدر: Blood, Vol. 125, No 24 (2015) pp. 3711-3719
مصطلحات موضوعية: Benzamides / toxicity, Male, Piperazines / administration & dosage, medicine.medical_treatment, Biochemistry, Gastroenterology, Piperazines, Pyrimidines / toxicity, hemic and lymphatic diseases, Antineoplastic Combined Chemotherapy Protocols, Medicine, Philadelphia Chromosome, Piperazines / therapeutic use, Protein Kinase Inhibitors / therapeutic use, Piperazines / toxicity, ddc:616, Precursor Cell Lymphoblastic Leukemia-Lymphoma / therapy, Protein Kinase Inhibitors / administration & dosage, Antineoplastic Combined Chemotherapy Protocols / toxicity, Hematology, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Middle Aged, Pyrimidines / administration & dosage, Treatment Outcome, Benzamides, Imatinib Mesylate, Female, Precursor Cell Lymphoblastic Leukemia-Lymphoma / drug therapy, medicine.drug, Adult, medicine.medical_specialty, Vincristine, Adolescent, Cyclophosphamide, Benzamides / therapeutic use, Immunology, Benzamides / administration & dosage, Disease-Free Survival, Young Adult, Internal medicine, Acute lymphocytic leukemia, Antineoplastic Combined Chemotherapy Protocols / therapeutic use, Pyrimidines / therapeutic use, Humans, Protein Kinase Inhibitors, Protein Kinase Inhibitors / toxicity, Chemotherapy, Precursor Cell Lymphoblastic Leukemia-Lymphoma / genetics, business.industry, Imatinib, Cell Biology, Antineoplastic Combined Chemotherapy Protocols / administration & dosage, medicine.disease, Surgery, Transplantation, Regimen, Pyrimidines, Imatinib mesylate, business, Stem Cell Transplantation
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::76ff7b8fa7c747ce8aaa642d7f259a20
https://doi.org/10.1182/blood-2015-02-627935 -
3
المؤلفون: Walter Vincken, Jacques De Keyser
المساهمون: Gerontology, Vriendenkring VUB, Clinical sciences, Rehabilitation Research
المصدر: Neurology. 35(2)
مصطلحات موضوعية: Levodopa, Pathology, medicine.medical_specialty, Parkinson's disease, Side effect, Case Report, Pharmacology, Tiapride, Middle Age, chemistry.chemical_compound, Medicine, Tiapride/*therapeutic use, Humans, Respiratory system, business.industry, Tiapamil Hydrochloride, Respiratory disease, Respiration Disorders/*chemically induced, Parkinson Disease, Middle Aged, medicine.disease, Respiration Disorders, nervous system diseases, chemistry, Respiratory failure, Levodopa/*adverse effects, Toxicity, Benzamides/*therapeutic use, Benzamides, Female, Neurology (clinical), business, Parkinson Disease/*drug therapy, medicine.drug, Human
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cfba8b44bdaa1764a4eff2454a5b3e96
https://pubmed.ncbi.nlm.nih.gov/3969212